An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Alpine Immune Sciences Announces Participation in May Investor Conferences
Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Alpine Immune Sciences, Inc. (Nasdaq: ALPN) will participate in two investor conferences in May 2022. The LifeSci Partners Immunology & Inflammation Symposium is scheduled for May 10 at 3:00 p.m. ET, featuring a fireside chat. The BofA Securities Healthcare Conference 2022 will occur on May 11 at 7:15 p.m. ET, where the company will present corporately. Webcasts of both events will be accessible on their investor relations website for 90 days after the live presentations. Alpine is focused on developing innovative immunotherapies for cancer and autoimmune diseases.
Positive
Participation in two significant investor conferences may enhance visibility and investor interest.
Alpine's commitment to developing innovative immunotherapies positions it well in a growing market.
Negative
None.
SEATTLE--(BUSINESS WIRE)--
Alpine Immune Sciences, Inc. (Nasdaq: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune and inflammatory diseases, today announced that members of its management team will participate at the following investor conferences in May 2022:
Webcasts of the LifeSci Partners fireside chat and BofA corporate presentation will be available online in the investor relations section of the company’s website at https://ir.alpineimmunesciences.com/events. A replay of the fireside chats will be available on the company website for 90 days following the webcast.
About Alpine Immune Sciences, Inc.
Alpine Immune Sciences is committed to leading a new wave of immune therapeutics. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine is seeking to create first- or best-in-class multifunctional immunotherapies via unique protein engineering technologies to improve patients’ lives. Alpine has entered into strategic collaborations with leading global biopharmaceutical companies and has a diverse pipeline of clinical and preclinical candidates in development. For more information, visit www.alpineimmunesciences.com. Follow @AlpineImmuneSci on Twitter and LinkedIn.
What conferences will Alpine Immune Sciences participate in May 2022?
Alpine Immune Sciences will participate in the LifeSci Partners Immunology & Inflammation Symposium on May 10 and the BofA Securities Healthcare Conference on May 11, 2022.
What is the date for Alpine's presentation at the BofA Securities Healthcare Conference?
Alpine's presentation at the BofA Securities Healthcare Conference is scheduled for May 11, 2022, at 7:15 p.m. ET.
Will the webcasts for Alpine's investor conferences be available for later viewing?
Yes, webcasts of both the LifeSci Partners fireside chat and BofA corporate presentation will be available online for 90 days after the events.
What is the stock symbol for Alpine Immune Sciences?
The stock symbol for Alpine Immune Sciences is ALPN.
Where can I find more information about Alpine Immune Sciences?
More information about Alpine Immune Sciences can be found on their official website at www.alpineimmunesciences.com.
